Key result
Selective NCX inhibition suppresses delayed afterdepolarizations, but early afterdepolarization and inotropic effects remain controversial.
Why the study?
Published results regarding the effects of Na+/Ca2+ exchanger inhibition are often controversial across different species, inhibitor compounds, and experimental conditions, leaving its clinical pharmacological future uncertain.
Does selective Na+/Ca2+ exchanger inhibition improve antiarrhythmic and inotropic parameters in preclinical experimental models?
Does selective Na+/Ca2+ exchanger inhibition improve antiarrhythmic and inotropic parameters in preclinical experimental models?
Highlights the complex, condition-dependent mechanisms of NCX inhibition and underscores the challenges in translating preclinical antiarrhythmic and inotropic findings to clinical utility.
Answers are grounded in this paper and cite their sources.
NCX inhibition may suppress triggered arrhythmias in models; leaves open clinical antiarrhythmic or inotropic utility due to species-dependent effects.
Life-long stable heart function requires a critical balance of intracellular Ca2+. Several ion channels and pumps cooperate in a complex machinery that controls the influx, release, and efflux of Ca2+. Probably one of the most interesting and most complex players of this crosstalk is the Na+/Ca2+ exchanger, which represents the main Ca2+ efflux mechanism; however, under some circumstances, it can also bring Ca2+ into the cell. Therefore, the inhibition of the Na+/Ca2+ exchanger has emerged as one of the most promising possible pharmacological targets to increase Ca2+ levels, to decrease arrhythmogenic depolarizations, and to reduce excessive Ca2+ influx. In line with this, as a response to increasing demand, several more or less selective Na+/Ca2+ exchanger inhibitor compounds have been developed. In the past 20 years, several results have been published regarding the effect of Na+/Ca2+ exchanger inhibition under various circumstances, e.g., species, inhibitor compounds, and experimental conditions; however, the results are often controversial. Does selective Na+/Ca2+ exchanger inhibition have any future in clinical pharmacological practice? In this review, the experimental results of Na+/Ca2+ exchanger inhibition are summarized focusing on the data obtained by novel highly selective inhibitors.
No takes yet. Share an insight, caveat, or question.
Nagy et al. (2022) conducted a review in Cardiac arrhythmias and impaired contractility. Selective Na+/Ca2+ exchanger (NCX) inhibitors was evaluated. Selective Na+/Ca2+ exchanger inhibition effectively suppresses delayed afterdepolarizations but shows controversial or species-dependent results regarding early afterdepolarizations and inotropic effects.
Synapse has enriched 10 related papers. Consider them for comparative context: